|
Volumn 70, Issue 7, 2013, Pages 664-665
|
Nitric oxide and symptom reduction in schizophrenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE;
CYCLIC GMP;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITROPRUSSIDE SODIUM;
PLACEBO;
REACTIVE OXYGEN METABOLITE;
ALLOSTERISM;
BRAIN PERFUSION;
BRAIN REGION;
CEREBELLUM;
CLINICAL TRIAL (TOPIC);
COGNITIVE DEFECT;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
HYPERTENSION;
NERVE CELL PLASTICITY;
OXIDATIVE STRESS;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SCHIZOPHRENIA;
TREATMENT RESPONSE;
VASODILATATION;
|
EID: 84880552098
PISSN: 2168622X
EISSN: None
Source Type: Journal
DOI: 10.1001/jamapsychiatry.2013.210 Document Type: Editorial |
Times cited : (18)
|
References (9)
|